Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |